Drug application
POTASSIUM PHOSPHATES (POTASSIUM PHOSPHATE, DIBASIC, POTASSIUM PHOSPHATE, MONOBASIC)
Drugs@FDA NDA 212121 · CMP DEV LLC
Key facts
| Drug name | POTASSIUM PHOSPHATES |
|---|---|
| Active ingredients | POTASSIUM PHOSPHATE, DIBASIC, POTASSIUM PHOSPHATE, MONOBASIC |
| Application type | NDA |
| Application number | 212121 |
| Company | CMP DEV LLC |
| Dosage forms | SOLUTION, INTRAVENOUS |
| Strength | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Sep 19, 2019 |
At a glance
- 1–9 Submissions
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: